A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies (Q6627253)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies |
scientific article; zbMATH DE number 7934066
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies |
scientific article; zbMATH DE number 7934066 |
Statements
A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies (English)
0 references
29 October 2024
0 references
immunotherapy
0 references
optimal biological dose
0 references
phase I/II
0 references
targeted therapy
0 references
utility-based design
0 references
0 references
0 references
0 references
0 references
0 references
0 references
